Houston, TX – A multi-million dollar scheme to consolidate power in the intellectual and developmental disabilities healthcare market has been busted by the Federal Trade Commission. Centerbridge Seaport Acquisition Fund, the financial muscle behind the attempted takeover of BrightSpring Health Services, Inc., is facing a forced breakup after regulators flagged a dangerous antitrust violation. The deal, valued at a staggering $835 million, would have handed a massive chunk of the IDD care market to Sevita Health, creating a near-monopoly in several key states.
The FTC didn’t hesitate to intervene, recognizing the potential for diminished quality of care and inflated prices for vulnerable individuals and their families. Investigators determined that allowing Sevita to absorb BrightSpring’s community living business would have substantially lessened competition, leaving families with fewer options and potentially compromising the standard of care for those relying on these critical services.
A Forced Divestiture
Instead of a full block of the acquisition, the FTC negotiated a consent order forcing Sevita to spin off 128 intermediate care facilities (ICFs) – facilities providing essential services to individuals with intellectual and developmental disabilities. These aren’t just buildings; they’re homes and lifelines for some of the most vulnerable members of our society. The divested facilities, located in Indiana, Louisiana, and Texas, will be acquired by Dungarvin Group, Inc., a company with a proven track record in IDD care. This move aims to preserve competition and ensure continued access to quality services.
Sources close to the investigation tell GrimyTimes.com that the FTC was particularly concerned about the concentrated market power Sevita would wield in these states. “This wasn’t about stopping a business deal; it was about protecting patients,” said one source, speaking on condition of anonymity. “Sevita’s acquisition of BrightSpring would have given them an unacceptable level of control, allowing them to dictate terms and potentially cut corners.”
The forced divestiture sends a clear message to private equity firms and healthcare conglomerates: attempts to monopolize essential services, especially those serving vulnerable populations, will not be tolerated. While the FTC’s action prevents the immediate consolidation, questions remain about the broader trend of private equity’s increasing involvement in the healthcare sector and the potential for similar anti-competitive practices down the line.
Key Facts:
- Defendant: Centerbridge Seaport Acquisition Fund
- Crime: Antitrust Violation – Attempted monopolization of IDD healthcare market
- Affected States: Indiana, Louisiana, Texas
- Acquisition Value: $835 million (BrightSpring Health Services, Inc.)
- Divestiture: 128 intermediate care facilities (ICFs) to be sold to Dungarvin Group, Inc.
- FTC Action: Proposed consent order requiring divestiture to resolve antitrust concerns.
GrimyTimes.com will continue to follow this case and report on any further developments. The fight to protect vulnerable populations from predatory business practices is far from over.
Source: FTC.gov
Related Federal Cases
- Ticketmaster, Antitrust Violation, New York NY, 2023 · Massachusetts
- Live Nation, Antitrust Lawsuit, New York NY, 2024 · Massachusetts
- XPLOR Energy SPV-1, Inc, Clean Water Act Violation, Texas 2023 · Indiana
- Hot Springs Man Sentenced for PPP UI Fraud, Hot Springs AR, 2023 · Washington
- John Doe, ATM Smash and Grab, Texas, 2023 · Washington

